Evaluation of D-dimer Levels for the Differential Diagnosis of Acute Chest Pain in Hong Kong: A Single-Centre Retrospective Study D-dimer for Chest Pain Diagnoses

Background D-dimer is elevated in acute aortic syndrome (AAS) and pulmonary embolism (PE), but local comparative data is limited. This study explores D-dimer's diagnostic value for AAS to inform acute chest pain management. Methods This retrospective single-centre study in Hong Kong evaluated adult emergency department (ED) patients presenting with chest pain between 2020 and 2025. Patients with D-dimer testing were grouped by diagnosis: AAS, PE, ischaemic heart disease (IHD), or non-specific chest pain (CP). Outcomes included D-dimer levels, diagnostic performance of D-dimer for AAS and PE, computed tomography (CT) utilization, 7- and 30-day mortality, hospital length of stay, and 28-day readmission rates. Results Among 1,019 included patients, median D-dimer levels were 329, 531, 3738, and 4693 ng/mL for CP, IHD, PE, and AAS, respectively. The AUROC for distinguishing AAS from non-AAS was 0.84 (95% CI: 0.79–0.89). D-dimer ≥ 2000 ng/mL was associated with significantly higher mortality. ED-based CT scans were performed in only 3 (27.3%) of AAS and 15 (6.3%) of PE patients. Conclusions This study reports the first local data characterising D-dimer levels across acute chest pain aetiologies, with the highest values observed in AAS and PE. The notably low CT rates in both the AAS and PE groups highlight an unanswered clinical need, and prospective multicentre studies integrating biomarkers with validated clinical decision tools are warranted to optimise risk stratification and CT utilisation for high-risk ED patients with chest pain.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11120949/v1
Primary Topic
Aortic Disease and Treatment Approaches
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Evaluation of D-dimer Levels for the Differential Diagnosis of Acute Chest Pain in Hong Kong: A Single-Centre Retrospective Study D-dimer for Chest Pain Diagnoses

K Li, Colin Alexander Graham, Kevin Kei Ching Hung, Ling Yan Leung et al.
Research Square
Aortic Disease and Treatment Approaches
preprint

Evaluation of D-dimer Levels for the Differential Diagnosis of Acute Chest Pain in Hong Kong: A Single-Centre Retrospective Study D-dimer for Chest Pain Diagnoses

K Li, Colin Alexander Graham, Kevin Kei Ching Hung, Ling Yan Leung, Shin Yan Man, Rebecca Sin Tung Li, Raymond Chi Hung Cheng, Giles Cattermole
preprint en

Abstract

Background D-dimer is elevated in acute aortic syndrome (AAS) and pulmonary embolism (PE), but local comparative data is limited. This study explores D-dimer's diagnostic value for AAS to inform acute chest pain management. Methods This retrospective single-centre study in Hong Kong evaluated adult emergency department (ED) patients presenting with chest pain between 2020 and 2025. Patients with D-dimer testing were grouped by diagnosis: AAS, PE, ischaemic heart disease (IHD), or non-specific chest pain (CP). Outcomes included D-dimer levels, diagnostic performance of D-dimer for AAS and PE, computed tomography (CT) utilization, 7- and 30-day mortality, hospital length of stay, and 28-day readmission rates. Results Among 1,019 included patients, median D-dimer levels were 329, 531, 3738, and 4693 ng/mL for CP, IHD, PE, and AAS, respectively. The AUROC for distinguishing AAS from non-AAS was 0.84 (95% CI: 0.79–0.89). D-dimer ≥ 2000 ng/mL was associated with significantly higher mortality. ED-based CT scans were performed in only 3 (27.3%) of AAS and 15 (6.3%) of PE patients. Conclusions This study reports the first local data characterising D-dimer levels across acute chest pain aetiologies, with the highest values observed in AAS and PE. The notably low CT rates in both the AAS and PE groups highlight an unanswered clinical need, and prospective multicentre studies integrating biomarkers with validated clinical decision tools are warranted to optimise risk stratification and CT utilisation for high-risk ED patients with chest pain.

Research Square
Hospital Authority (HK), Chinese University of Hong Kong (HK)
Aortic Disease and Treatment Approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon